Delivery Order SPE2DB22D1106-SPE2DB25FDJG8
Award Date
10/29/24
Potential Completion Date
10/30/24
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,333.48 firm-fixed-price delivery order is for the supply of Lacosamide 10 mg/ml solution, a pharmaceutical product. The contract has an ultimate completion date of January 28, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,433.62, is for the delivery of Lacosamide 10 mg/ml solution (200 ml) and has an ultimate completion date of December 3, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award is for the delivery of Lacosamide 10 mg/ml solution in 200 ml containers, valued at $1,292.14. The award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is October 21, 2024. The contract was not set aside for any specific business category. This award is associated with a larger Indefinite...
This federal contract award is for the supply of Lacosamide 10 mg/ml solution, a prescription medication, to the Defense Logistics Agency (DLA) by AmerisourceBergen Drug Corp. The contract is a delivery order with a firm fixed-price of $2,517.72 and an ultimate completion date of August 2, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract as well as multiple Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of...
This federal contract award is a delivery order (SPE2DB23FQ83W) issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,227.21 firm fixed-price contract is for the provision of 4,558,866,579 units of Lacosamide 100 mg tablets. The award has an ultimate completion date of October 25, 2022. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is a firm fixed price delivery order for the supply of Lacosamide 100 mg/10 ml pharmaceutical products, with an ultimate completion date of April 2, 2024 and a ceiling value of $1,000.12. Amerisourcebergen Drug Corporation, through its Corporate Office...
This federal contract award, valued at $1,352.73, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of LACOSAMIDE 150 MG TABLET 60S, with an ultimate completion date of March 17, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Lacosamide, a medication used to treat certain types of seizures, with a ceiling value of $1,535.76 and an ultimate completion date of August 23, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen Drug Corp holds several Indefinite Delivery...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Lacosamide 10 mg/ml solution, a pharmaceutical product, with a ceiling value of $1,450.68 and a performance period through June 12, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,848.52 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that runs through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical...